FDX1 and cholestasis: These results establish a direct link between FDX1-mediated taurocholic acid-exacerbated cuproptosis and cholestasis-induced hepatotoxicity, providing both theoretical and experimental foundations for developing novel therapeutic strategies against cholestatic liver injury.